Progress in Vaccinology

Detalles Bibliográficos
Autor principal: Talwar, G. P. (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 1989.
Edición:1st ed. 1989.
Colección:Progress in Vaccinology, 2
Materias:
Acceso en línea:https://doi.org/10.1007/978-1-4612-3508-8
LEADER 05006nam a22004215i 4500
001 978-1-4612-3508-8
005 20191024211256.0
007 cr nn 008mamaa
008 121227s1989 xxu| s |||| 0|eng d
020 |a 9781461235088 
024 7 |a 10.1007/978-1-4612-3508-8  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
100 1 |a Talwar, G. P.  |e author. 
245 1 0 |a Progress in Vaccinology  |c by G. P. Talwar. 
246 3 |a The papers in this volume were presented at Symposium on Progress in Vaccinology, 1-5 December 1986, New Delhi, India 
250 |a 1st ed. 1989. 
260 # # |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 1989. 
300 |a XX, 483 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Progress in Vaccinology,  |v 2 
505 0 |a I Opening Remarks -- 1. Vaccinology: The Two Revolutions -- II Public Health Perspective—The Present Scene -- 2. Vaccinology and the Goal of Health for All -- 3. Toward Universal Immunization: 1990 -- 4. New and Improved Techniques for Vaccine Production -- 5. Transfer of Vaccine Production to the Developing World: Rabies Vaccine -- 6. Policy for Developing Countries for Storage, Distribution, and Use of Essential Vaccines for Immunoprophylaxis -- III Environmental Factors Modulating The Efficacy of The Vaccine -- 7. Immunity in Tuberculosis: Environmental Versus Intrinsic Factors Modulating the Immune Responsiveness to Mycobacteria -- 8. Geographic Variation in Vaccine Efficacy: The Polio Experience -- IV Hepatitis -- 9. Molecular Immunology of Viral Antigens in Hepatitis B Vaccinations -- 10. Biologic Significance of Pre-S Antigen and Anti-Pre-S Antibodies in Hepatitis B Virus Infection -- 11. Enterically Transmitted Hepatitis Viruses: Prospects for Control -- 12. Immunological Characterization of a Viral Agent Involved in Epidemic and Sporadic Non-A Non-B Hepatitis -- V Gastrointestinal Infections -- 13. Attenuated Oral Typhoid Vaccine Ty 21a -- 14. Oral B Subunit—Whole Cell Vaccine Against Cholera: From Basic Research to Successful Field Trial -- 15. Prospects of Immunization Against Cholera by Adhesive Antigen -- 16. Protective Antigens of Vibrio cholerae -- 17. Rationale for the Development of a Rotavirus Vaccine for Infants and Young Children -- 18. Mucosal Immunity in the Gastrointestinal Tract in Relation to ETEC Vaccine Development -- 19. Shigella Vaccines -- 20. DNA Sequence Homology Among Genes of Shigella spp. and Enteroinvasive Escherichia coli.. -- 21. Mucosal and Acquired Immunity in Giardiasis and Its Relation to Diarrhea and Malabsorption -- 22. Immunology of Entamoeba histolytica in Human and Experimental Hosts -- 23. Molecular Comparisons Among Entamoeba histolytica Strains Using DNA and Protein Profiles -- VI Filariasis -- 24. Importance of Antibody Class in Helminth Infections -- 25. Immunodiagnosis of Filariasis -- VII Veterinary Vaccines -- 26. Development, Production, and Application of Vaccines in Foot-and-Mouth Disease Control in India -- 27. Cell Culture Vaccine Against Bovine Tropical Theileriosis -- VIII Leprosy -- 28. Present Approaches to Immunotherapy and Immunoprophylaxis for Leprosy -- 29. Armadillo-Derived Killed M. leprae: Candidate Vaccine Against Leprosy -- 30. Mycobacterium w: Candidate Vaccine Against Leprosy with Antigens Cross-Reactive with Three Major Protein Antigens of Mycobacterium leprae -- 31. Molecular Approaches to Developing a Vaccine for Leprosy, -- 32. Immunodiagnosis of Leprosy -- 33. Immunodiagnostic Approaches to the Detection of M. leprae Infection in Leprosy -- 34. Serological Survey of Leprosy Using a Monoclonal Antibody-Based Immunoassay and Phenolic Glycolipid ELISA -- IX Malaria and Leishmaniasis -- 35. Antisporozoite Malaria Vaccine Development Based on Circumsporozoite Protein -- 36. Malaria Sporozoite Vaccine Development: Recent Progress -- 37. Community-Based Integrated Vector Control of Malaria in India -- 38. Leishmaniasis and Malaria: New Tools for Epidemiological Analysis -- X New Approaches to Vaccinology -- 39. Vaccinia Virus Expression Vectors -- 40. Vaccinia Recombinants Expressing Foreign Antigens: Antiviral and Antitumor Immunity -- 41. Liposomes as Carriers of Vaccines -- 42. A Short Primer on Vaccine Design: Focus on the Interrelatedness of Antigenic Determinants Addressing Various Lymphocyte Sub-populations -- 43. Next Steps in the Evolution of Vaccinology. 
650 0 |a Life sciences. 
650 0 |a Hepatology. 
650 0 |a Gastroenterology . 
650 0 |a Allergy. 
650 0 |a Medical microbiology. 
650 0 |a Immunology. 
650 1 4 |a Life Sciences, general. 
650 2 4 |a Hepatology. 
650 2 4 |a Gastroenterology. 
650 2 4 |a Allergology. 
650 2 4 |a Medical Microbiology. 
650 2 4 |a Immunology. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
856 4 0 |u https://doi.org/10.1007/978-1-4612-3508-8